Pharmaceuticals

Tue, 07/13/2010 - 18:07

Merck to inject $147.70 mln into new Hangzhou facility

Shanghai. July 13. INTERFAX-CHINA - U.S.-based Merck & Co. Inc. (Merck) has signed an agreement with Hangzhou Municipal Government to build a new manufacturing plant costing RMB 1 billion ($147.70 million), the municipal government announced on its Web site July 12.

This article is only accessible to Interfax subscribers. To gain access to this article, as well similar in-depth articles and industry-specific content, please contact our sales staff by telephone (+852 2537 2262) .

Start free trial NOW